Subtype
Female Reproductive System Neoplasm
CI-CAN-00000885Explore in graph →
Non-malignant1,633 active trials11 approved drugs139 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000885Explore in graph →
Clinical trials
7,174 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02766582 | Phase II: Pembrolizumab/Carboplatin/Taxol in Epithelial Ovary Cancer | completed | Phase 2 | 29 | Medical College of WisconsinOTHER | 1 | Feb 26, 2024 | clinicaltrials |
| NCT00516373 | A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of Poly ADP-Ribose Polymerase-1 (PARP) | completed | Phase 1 | 98 | AstraZenecaINDUSTRY | 4 | Feb 22, 2024 | clinicaltrials |
| Prevention and Screening Towards Elimination of Cervical Cancer(PRESCRIP-TEC) |
| completed |
| N/A |
| 30,000 |
| University Medical Center GroningenOTHER |
| 1 |
| Feb 22, 2024 |
| clinicaltrials |
| NCT02728830 | A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers | completed | Early Phase 1 | 39 | AA SecordOTHER | 1 | Feb 21, 2024 | clinicaltrials |
| NCT02901899 | Guadecitabine and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | completed | Phase 2 | 45 | Northwestern UniversityOTHER | 1 | Feb 20, 2024 | clinicaltrials |
| NCT03936270 | Palbociclib Plus Letrozole Treatment After Progression to Second Line Chemotherapy for Women With ER/PR-positive Ovarian Cancer | completed | Phase 2 | 43 | Latin American Cooperative Oncology GroupOTHER | 1 | Feb 20, 2024 | clinicaltrials |
| NCT03476798 | Bevacizumab and Rucaparib in Recurrent Carcinoma of the Cervix or Endometrium(Clovis-001) | completed | Phase 2 | 49 | University of OklahomaOTHER | 1 | Feb 15, 2024 | clinicaltrials |
| NCT06253559 | Clinical and Pathological Characteristics of Women With Ovarian Cancers in Syria | completed | — | 531 | Latakia UniversityOTHER | 1 | Feb 15, 2024 | clinicaltrials |
| NCT06254781 | Luspatercept in Metastatic AGCT of the Ovary | completed | N/A | 1 | University Health Network, TorontoOTHER | 1 | Feb 12, 2024 | clinicaltrials |
| NCT02494063 | Sentinel Lymph Node Biopsy in Patients With Early Stages Cervical Cancer(SENTIX) | completed | — | 600 | Charles University, Czech RepublicOTHER | 1 | Feb 8, 2024 | clinicaltrials |
| NCT03015129 | A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer | completed | Phase 2 | 80 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 6, 2024 | clinicaltrials |
| NCT05188716 | Mechanisms and Biomarkers for Tumor Immunogenicity Modulation in Cervical Cancer | completed | — | 30 | Chuangzhen ChenOTHER | 1 | Feb 6, 2024 | clinicaltrials |
| NCT05564286 | Triple Antiemetic Regimen for Chemoradiotherapy in Cervical Cancer or Nasopharyngeal Cancer | completed | Phase 3 | 116 | Shantou University Medical CollegeOTHER | 1 | Feb 6, 2024 | clinicaltrials |
| NCT04111835 | HPV Testing In Polish POpulation-based Cervical Cancer Screening Program.(HIPPOPROJECT) | completed | N/A | 33,000 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Feb 2, 2024 | clinicaltrials |
| NCT05179122 | Effectiveness of Wound Drains for the Prevention Of Surgical sITe infectION(POSITION) | completed | N/A | 200 | National and Kapodistrian University of AthensOTHER | 1 | Feb 2, 2024 | clinicaltrials |
| NCT05529303 | Prolonged Grief and Perception of Femininity in Gynecological Cancer Patients | completed | N/A | 80 | Kevser PamukOTHER | 1 | Feb 1, 2024 | clinicaltrials |
| NCT01350908 | Study of Circulating Tumoral DNA in Ovarian Cancer | completed | N/A | 25 | Institut CurieOTHER | 1 | Jan 31, 2024 | clinicaltrials |
| NCT05490407 | Role of the ATP7A Transporter in Ovarian Cancer(ATHOC) | completed | N/A | 40 | University Medical Centre LjubljanaOTHER | 1 | Jan 30, 2024 | clinicaltrials |
| NCT05074472 | A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors | completed | Phase 1 / Phase 2 | 35 | ZielBio, Inc.INDUSTRY | 1 | Jan 29, 2024 | clinicaltrials |
| NCT06070363 | Effectiveness of Manual Acupuncture and Standard Therapy Compared to Standard Therapy in Gynecological Cancer Pain | completed | N/A | 58 | Indonesia UniversityOTHER | 1 | Jan 29, 2024 | clinicaltrials |
| NCT06073496 | The Effectiveness of Electroacupuncture and Standard Therapy Compared to Standard Therapy in Gynecological Cancer Pain | completed | N/A | 58 | Indonesia UniversityOTHER | 1 | Jan 29, 2024 | clinicaltrials |
| NCT06226350 | A Phase Ⅱ Study of F520 in Patients With Cervical Carcinoma | completed | Phase 2 | 29 | Shandong New Time Pharmaceutical Co., LTDINDUSTRY | 1 | Jan 26, 2024 | clinicaltrials |
| NCT04066361 | OPTimizing Treatment Focused Genetic Testing IN Cancer(OPT-IN) | completed | N/A | 301 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 25, 2024 | clinicaltrials |
| NCT03117933 | Olaparib +/- Cediranib or Chemotherapy in Patients With Platinum-resistant Ovarian Cancer(OCTOVA) | completed | Phase 2 | 139 | University of OxfordOTHER | 1 | Jan 23, 2024 | clinicaltrials |
| NCT02517554 | A Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic Services | completed | — | 120 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jan 19, 2024 | clinicaltrials |
| NCT04330716 | Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers(GeneBOPP) | completed | N/A | 269 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 19, 2024 | clinicaltrials |
| NCT04803305 | Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia | completed | Phase 1 | 18 | PfizerINDUSTRY | 2 | Jan 12, 2024 | clinicaltrials |
| NCT00342446 | A Follow-up Study of Women Evaluated and Treated for Infertility | completed | — | 12,193 | National Cancer Institute (NCI)NIH | 1 | Jan 11, 2024 | clinicaltrials |
| NCT02865135 | Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer | completed | Phase 1 / Phase 2 | 11 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 11, 2024 | clinicaltrials |
| NCT04212377 | Dendritic Cells for Immunotherapy of Metastatic Endometrial Cancer Patients(DECENDO) | completed | Phase 2 | 8 | Radboud University Medical CenterOTHER | 1 | Jan 11, 2024 | clinicaltrials |
| NCT04626466 | Effect of Irradiation Doses < 10 Gy and of Irradiated Bone Volume on the Variation of Blood Elements of the Complete Blood Count During and After Pelvic Irradiation(MIFADORESOL) | completed | — | 100 | Institut de cancérologie Strasbourg EuropeOTHER | 1 | Jan 11, 2024 | clinicaltrials |
| NCT06201221 | Single-port Laparoscopy in Children and Adolescents | completed | — | 300 | Fujian Maternity and Child Health HospitalOTHER | 1 | Jan 11, 2024 | clinicaltrials |
| NCT02915523 | Study of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian Cancer | completed | Phase 1 / Phase 2 | 140 | Syndax PharmaceuticalsINDUSTRY | 1 | Jan 10, 2024 | clinicaltrials |
| NCT05213078 | Family Caregivers in Underserved Populations Providing Complex Cancer Care | completed | N/A | 48 | City of Hope Medical CenterOTHER | 1 | Jan 5, 2024 | clinicaltrials |
| NCT05977829 | Endometrial Malignancy in Breast Cancer Patients With or Without AUB(TamAUB) | completed | — | 283 | University of Campania Luigi VanvitelliOTHER | 1 | Dec 26, 2023 | clinicaltrials |
| NCT03219268 | A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms | completed | Phase 1 | 277 | MacroGenicsINDUSTRY | 8 | Dec 21, 2023 | clinicaltrials |
| NCT03454451 | CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers | completed | Phase 1 | 117 | Corvus Pharmaceuticals, Inc.INDUSTRY | 2 | Dec 21, 2023 | clinicaltrials |
| NCT04168242 | Scalp Cooling in Gynecologic Cancer Patients | completed | N/A | 80 | The University of Hong KongOTHER | 1 | Dec 20, 2023 | clinicaltrials |
| NCT06177236 | Clinic or Self-Sampling for Cervical Cancer Screening | completed | N/A | 110 | Istanbul University - CerrahpasaOTHER | 1 | Dec 20, 2023 | clinicaltrials |
| NCT02481414 | A Clinical Trial of PepCan to Two Therapy Arms for Treating Cervical High-Grade Squamous Intraepithelial Lesions | completed | Phase 2 | 81 | University of ArkansasOTHER | 1 | Dec 18, 2023 | clinicaltrials |
| NCT04590599 | A Phase II Clinical Study to Assess the Efficacy and Safety of IBI310 or Placebo Combined With Sintilimab for Advanced Cervical Cancer Subjects Who Have Failed or Cannot Tolerate First-line or Above Platinum-based Chemotherapy | completed | Phase 2 | 205 | Innovent Biologics (Suzhou) Co. Ltd.INDUSTRY | 1 | Dec 18, 2023 | clinicaltrials |
| NCT04284852 | Niraparib Maintenance in Patients With Advanced Ovarian Cancer at Neoadjuvant Setting(NEOPRIMA) | completed | Phase 2 | 20 | The University of Hong KongOTHER | 1 | Dec 15, 2023 | clinicaltrials |
| NCT04405349 | Investigating the Combination of VB10.16 and Atezolizumab in Patients With HPV 16-positive Cervical Cancer | completed | Phase 2 | 52 | Nykode Therapeutics ASAINDUSTRY | 6 | Dec 15, 2023 | clinicaltrials |
| NCT02494037 | The Canadian/US Integrative Oncology Study(CUSIOS) | completed | — | 400 | The Canadian College of Naturopathic MedicineOTHER | 2 | Dec 14, 2023 | clinicaltrials |
| NCT03211481 | Design of an Intra-operative Blood Conservation Pathway at Open Myomectomy | completed | — | 24 | Unity Health TorontoOTHER | 1 | Dec 13, 2023 | clinicaltrials |
| NCT01402271 | Pazopanib Hydrochloride, Paclitaxel, and Carboplatin in Treating Patients With Refractory or Resistant Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer | completed | Phase 1 / Phase 2 | 88 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Dec 11, 2023 | clinicaltrials |
| NCT02413606 | ENdometrial Cancer SURvivors' Follow-up carE (ENSURE): Less is More?(ENSURE) | completed | N/A | 319 | Comprehensive Cancer Centre The NetherlandsOTHER | 1 | Dec 6, 2023 | clinicaltrials |
| NCT04262089 | Neo-adjuvant Pembrolizumab in dMMR/ POLE-EDM Uterine Cancer Patients: a Feasibility Study(PAM) | completed | Phase 1 | 10 | University Medical Center GroningenOTHER | 1 | Dec 5, 2023 | clinicaltrials |
Data updated 24 days agoSource updated Feb 26, 2024source: clinicaltrials